Maca root has been the subject of a modest but growing body of human clinical research, mostly small randomized controlled trials conducted in Peru, the United States, and Europe. This article summarizes what those trials have actually measured and found, without overstating conclusions the research does not support.
Libido and Sexual Function Trials
Several small randomized, double-blind, placebo-controlled trials have examined maca’s effect on self-reported sexual desire in both men and women. The general pattern across these trials is a modest improvement in libido scores compared to placebo, typically measured over 6 to 12 weeks. A 12-week double-blind trial in men aged 21 to 56 found improved sexual desire from week 8 onward, and showed it was not explained by changes in serum testosterone, estradiol, or depression and anxiety scores[1].
A separate 12-week trial in 50 men with mild erectile dysfunction found larger gains on maca than on placebo[2]. The picture is not unanimous, though: a systematic review of the randomised evidence found two of four trials showed a significant effect on sexual desire or dysfunction, while a trial in healthy cyclists showed none[3].
Importantly, most of these trials measured subjective desire rather than physiological arousal or sexual function outcomes directly, and sample sizes have generally been small (often under 100 participants), which limits how confidently the findings generalize. The systematic review of maca for sexual function identified only four randomised trials in total[3].
Menopause Symptom Trials
A handful of trials have looked at maca for menopausal symptoms including hot flashes, mood changes, and sleep disruption in perimenopausal and postmenopausal women. Two crossover trials reported improvements in psychological symptom scores (anxiety and depression subscales) without corresponding changes in reproductive hormone levels.
A trial in postmenopausal women found significantly reduced Greene Climacteric psychological subscale scores with no difference in estradiol, follicle-stimulating hormone, luteinizing hormone or sex hormone-binding globulin[4]. A later crossover trial in 29 postmenopausal women found lower depression scores and lower diastolic blood pressure, again with no difference in estradiol, follicle-stimulating hormone, thyroid-stimulating hormone or sex hormone-binding globulin[5]. That pattern supports a non-hormonal mechanism rather than an estrogen-like effect.
Results have been mixed on vasomotor symptoms specifically (hot flashes and night sweats), with some trials showing benefit and others showing no significant difference from placebo. A systematic review of four randomised trials in menopausal women concluded that the evidence for maca on menopausal symptoms is limited, chiefly because of how few trials exist and their methodological quality[6].
Male Fertility and Sperm Parameter Trials
A smaller set of studies has examined maca’s effect on semen quality markers such as sperm concentration and motility in men. An early uncontrolled study in nine men reported increases in seminal volume, sperm count and sperm motility after four months, with no change in serum hormones[7].
A later randomised, double-blind, placebo-controlled trial in 69 men with mild sperm abnormalities found a significant improvement in sperm concentration, but no significant difference from placebo in motility, semen volume or morphology[8]. A 2022 systematic review and meta-analysis pooling five randomised trials was then unable to confirm even the concentration effect, and described the overall evidence on semen quality as unclear[9]. Taken together, this is not yet a body of evidence that supports maca as a fertility treatment.
Limitations Across the Research Base
Across nearly all maca trials, common limitations include small sample sizes, short study durations, reliance on self-reported outcome measures, and inconsistent dosing and maca preparation types between studies. Several systematic reviews of the maca literature have concluded that while findings are promising, the evidence base is not yet strong enough to make firm clinical recommendations. The reviews covering sexual function[3], menopausal symptoms[6] and semen quality[9] each reach that conclusion independently.
This does not mean maca does not work. It means the current research supports cautious optimism rather than confident claims, and anyone considering maca should weigh that uncertainty honestly.
Frequently Asked Questions
Are maca clinical trials peer-reviewed?
Most published maca trials appear in peer-reviewed journals, though the overall body of research remains smaller than for more heavily studied supplements.
Has maca been compared directly to prescription treatments in trials?
Direct head-to-head trials against prescription hormone therapy or fertility medications are rare. Most maca trials compare it to placebo, not to an active pharmaceutical comparator.
Do trial results differ by maca color or form?
Some studies suggest different colored maca varieties (red, black, yellow) may perform differently for specific outcomes, but this area needs more direct comparative research before firm conclusions can be drawn.
References
- Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia, 2002
- Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial. Andrologia, 2009
- Maca (L. meyenii) for improving sexual function: a systematic review. BMC complementary and alternative medicine, 2010
- Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause (New York, N.Y.), 2008
- Maca reduces blood pressure and depression, in a pilot study in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2015
- Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review. Maturitas, 2011
- Lepidium meyenii (Maca) improved semen parameters in adult men. Asian journal of andrology, 2001
- Does Lepidium meyenii (Maca) improve seminal quality?. Andrologia, 2020
- Maca (Lepidium meyenii Walp.) on semen quality parameters: A systematic review and meta-analysis. Frontiers in pharmacology, 2022
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.




